...
首页> 外文期刊>Acta paediatrica. Supplement >Prevention of microvascular complications in diabetic children and adolescents.
【24h】

Prevention of microvascular complications in diabetic children and adolescents.

机译:预防糖尿病儿童和青少年的微血管并发症。

获取原文
获取原文并翻译 | 示例

摘要

Diabetes mellitus causes profound alterations in many body tissues. Microvascular diabetic complications include diabetic neuropathy, nephropathy and retinopathy. Nephropathy first becomes manifest with hyperfiltration and microalbuminuria. These functional changes evolve over several years to a stage of marked deterioration of renal function. The possible preventive measures are metabolic control, reduction of dietary protein intake and use of ACE-inhibitors. Metabolic control is also important for the prevention of diabetic retinopathy. In fact, patients with HbA1c higher than 10% have an increased risk of progression of retinopathy. Moreover, an accelerated progression of retinopathy has been observed in patients with systemic hypertension following the onset of microalbuminuria. It has been demonstrated that diabetic neuropathy can also be present during childhood; therefore, it is possible to detect electrophysiological abnormalities in children and adolescents with IDDM. Glycaemic and blood pressure control are, so far, the main means for possible prevention or modification of the natural history of diabetic microvascular complications. Tight glycaemic control may have beneficial effects for diabetic neuropathy. In addition, other preventive measures, such as aldose reductase inhibitors, gangliosides, neurotrophic vitamins, etc., have been studied in the last years. However, no conclusive results have been obtained so far.
机译:糖尿病会引起许多身体组织的深刻改变。微血管糖尿病并发症包括糖尿病性神经病,肾病和视网膜病。肾病首先表现为超滤和微量白蛋白尿。这些功能变化在几年内发展到肾功能显着恶化的阶段。可能的预防措施是代谢控制,减少饮食中蛋白质的摄入量以及使用ACE抑制剂。代谢控制对于预防糖尿病性视网膜病也很重要。实际上,HbA1c高于10%的患者发生视网膜病变的风险增加。此外,已经观察到在微量白蛋白尿发作后的系统性高血压患者中视网膜病变的进展加快。已经证明在儿童时期也可能存在糖尿病性神经病。因此,有可能检测IDDM儿童和青少年的电生理异常。迄今为止,血糖和血压控制是可能预防或改变糖尿病微血管并发症自然史的主要手段。严格的血糖控制可能对糖尿病性神经病具有有益的作用。此外,最近几年还研究了其他预防措施,例如醛糖还原酶抑制剂,神经节苷脂,神经营养性维生素等。但是,到目前为止尚未获得结论性的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号